Cargando…

Functional Abnormality Associated With Tau Deposition in Alzheimer’s Disease – A Hybrid Positron Emission Tomography/MRI Study

Objective: To investigate the characteristics of tau deposition and its impact on functional connectivity (FC) in Alzheimer’s disease (AD). Methods: Hybrid PET/MRI scans with [(18)F]-THK5317 and neuropsychological assessments were undertaken in 26 participants with AD and 19 healthy controls (HC). T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Liping, Zhou, Zhi, Liu, Linwen, Zhang, Jinming, Xie, Hengge, Zhang, Xiaojun, Zhu, Mingwei, Wang, Ruimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548365/ https://www.ncbi.nlm.nih.gov/pubmed/34721001 http://dx.doi.org/10.3389/fnagi.2021.758053

Ejemplares similares

In vivo imaging of tau deposition in Alzheimer’s disease using both [(18)F]-THK5317 and [(18)F]-S16: A pilot human study
por: Fu, Liping, et al.
Publicado: (2022)

Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography
por: Therriault, Joseph, et al.
Publicado: (2022)

Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease
por: Cho, Hanna, et al.
Publicado: (2020)

Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease
por: Leuzy, Antoine, et al.
Publicado: (2021)

Amyloid and Tau Positron Emission Tomography Imaging in Alzheimer’s Disease and Other Tauopathies
por: Maschio, Cinzia, et al.
Publicado: (2022)

Tau positron emission tomography in patients with cognitive impairment and suspected Alzheimer’s disease
por: Matsuda, Hiroshi, et al.
Publicado: (2023)

Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease
por: Janelidze, Shorena, et al.
Publicado: (2020)

(18)F-APN-1607 Tau Positron Emission Tomography Imaging for Evaluating Disease Progression in Alzheimer’s Disease
por: Xu, Xiaojun, et al.
Publicado: (2022)

Dissociation of Tau Deposits and Brain Atrophy in Early Alzheimer’s Disease: A Combined Positron Emission Tomography/Magnetic Resonance Imaging Study
por: Shigemoto, Yoko, et al.
Publicado: (2018)

Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms
por: Lyoo, Chul Hyoung, et al.
Publicado: (2018)

Tau Filaments and the Development of Positron Emission Tomography Tracers
por: Goedert, Michel, et al.
Publicado: (2018)

Topographic staging of tau positron emission tomography images
por: Schwarz, Adam J., et al.
Publicado: (2018)

Regional tau deposition measured by [(18)F]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer’s disease
por: Saint-Aubert, Laure, et al.
Publicado: (2016)

Characterization of an APP/tau rat model of Alzheimer’s disease by positron emission tomography and immunofluorescent labeling
por: Filip, Thomas, et al.
Publicado: (2021)

Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography
por: Wang, Yi Ting, et al.
Publicado: (2019)

Longitudinal Tau Positron Emission Tomography in Dementia with Lewy Bodies
por: Chen, Qin, et al.
Publicado: (2022)

Regional tau deposition and subregion atrophy of medial temporal structures in early Alzheimer's disease: A combined positron emission tomography/magnetic resonance imaging study
por: Sone, Daichi, et al.
Publicado: (2017)

Analysis of amyloid and tau deposition in Alzheimer's disease using (11)C-Pittsburgh compound B and (18)F-THK 5351 positron emission tomography imaging
por: Chanisa, Chotipanich, et al.
Publicado: (2020)

Positron emission tomography of tau in Iraq and Afghanistan Veterans with blast neurotrauma
por: Robinson, Meghan E., et al.
Publicado: (2019)

Alzheimer’s Dementia: The Emerging Role of Positron Emission Tomography
por: Tripathi, Shailendra Mohan, et al.
Publicado: (2021)

Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging
por: Ossenkoppele, Rik, et al.
Publicado: (2021)

Amyloid deposition in semantic dementia: a positron emission tomography study
por: Brown, Eric E., et al.
Publicado: (2016)

Longitudinal Assessment of Tau Pathology in Patients with Alzheimer’s Disease Using [(18)F]THK-5117 Positron Emission Tomography
por: Ishiki, Aiko, et al.
Publicado: (2015)

Imaging tau pathology in Alzheimer’s disease with positron emission tomography: lessons learned from imaging-neuropathology validation studies
por: Moscoso, Alexis, et al.
Publicado: (2022)

Optimum Differentiation of Frontotemporal Lobar Degeneration from Alzheimer Disease Achieved with Cross‐Sectional Tau Positron Emission Tomography
por: Josephs, Keith A., et al.
Publicado: (2022)

The hippocampal sparing subtype of Alzheimer’s disease assessed in neuropathology and in vivo tau positron emission tomography: a systematic review
por: Ferreira, Daniel, et al.
Publicado: (2022)

Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer Disease
por: Leuzy, Antoine, et al.
Publicado: (2023)

Sex differences in off-target binding using tau positron emission tomography
por: Smith, Ruben, et al.
Publicado: (2021)

Misery Perfusion and Tau Deposition in Atherosclerotic Major Cerebral Artery Disease: A (18)F-Florzolotau Positron Emission Tomography Study
por: Yamauchi, Hiroshi, et al.
Publicado: (2022)

Positron emission tomography
Publicado: (1995)

Positron Emission Tomography
por: Piepmeier, Joseph M.
Publicado: (1986)

Positron emission tomography
por: Paans, A M J
Publicado: (2006)

β-Amyloid discordance of cerebrospinal fluid and positron emission tomography imaging shows distinct spatial tau patterns
por: Jiang, Chenyang, et al.
Publicado: (2022)

Intelligent Labeling of Tumor Lesions Based on Positron Emission Tomography/Computed Tomography
por: Ye, Shiping, et al.
Publicado: (2022)

Deep learning application for the classification of Alzheimer’s disease using (18)F-flortaucipir (AV-1451) tau positron emission tomography
por: Park, Sang Won, et al.
Publicado: (2023)

Tau positron emission tomography imaging in tauopathies: The added hurdle of off-target binding
por: Lemoine, Laetitia, et al.
Publicado: (2018)

Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective
por: Ricci, Maria, et al.
Publicado: (2021)

Clinical Utility of Tau Positron Emission Tomography in the Diagnostic Workup of Patients With Cognitive Symptoms
por: Smith, Ruben, et al.
Publicado: (2023)

(18)F-Fluorodeoxyglucose positron emission tomography may not visualize radiation pneumonitis
por: Guo, Meiying, et al.
Publicado: (2019)

Tracking neuroinflammation in Alzheimer’s disease: the role of positron emission tomography imaging
por: Zimmer, Eduardo Rigon, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m9o9f1holf6pgetcsssjj6iljf